Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, Guangdong, China.
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, Guangdong, China
Perit Dial Int. 2019 Jul-Aug;39(4):382-389. doi: 10.3747/pdi.2018.00256. Epub 2019 May 23.
The present study was to investigate the changes in outcomes of incident patients who started peritoneal dialysis (PD) between 2006 - 2010 and 2011 - 2015 in Southern China.In this single-center cohort study, incident PD patients from January 1, 2006, to December 31, 2015, were enrolled. Collected data included baseline demographic, clinical, biochemical characteristics, and outcomes. Patients who initiated PD during 2006 - 2010 and 2011 - 2015 were followed up until December 31, 2011, and December 31, 2016, respectively. Peritonitis rate, patient survival, and technique survival were compared between the 2 incident cohorts.A total of 2,021 incident PD patients were enrolled, with a mean age of 47.2 ± 15.2 years, 40.6% female. Compared with the 2006 - 2010 cohort ( = 1,073), patients initiating PD during 2011 - 2015 ( = 948) were younger (46.2 ± 14.8 vs 48.1 ± 15.5 years, = 0.006), had similar baseline estimate glomerular filtration rate (eGFR) (5.81 ± 2.41 vs 5.81 ± 2.89 mL/min/1.73 m, = 0.109) and comparable percentage of diabetes mellitus (24.9% vs 25.7%, = 0.682). The overall peritonitis rate in the 2011 - 2015 cohort was lower than in the 2006 - 2010 cohort (0.158 vs 0.161 episodes per year, = 0.001). At the end of 1, 3, and 5 years, the 2006 - 2010 and 2011 - 2015 cohorts had patient survival rates of 94%, 82%, 64%, and 97%, 87%, 74%, respectively ( < 0.001). After multivariable adjustment, patients starting PD in 2011 - 2015 were associated with lower risk of all-cause mortality (hazard ratio [HR] 0.77, 95% confidence interval [CI] 0.60 - 0.98). In gender and age-stratified models, male patients had a significantly lower risk of all-cause mortality (HR 0.58, 95% CI 0.41 - 0.83), and patients with age < 65 years showed a significantly lower risk of cardiovascular (CV) mortality (HR 0.63, 95% CI 0.40 - 0.99) in 2011 - 2015 compared with 2006 - 2010. The death-censored technique survival rates were not significantly different between the 2 cohorts ( = 0.234).Peritonitis rates and patient survival on PD continue to improve. Patients initiating PD between 2011 and 2015 were associated with better outcomes.
本研究旨在探讨中国南方地区 2006-2010 年和 2011-2015 年期间开始腹膜透析(PD)的新发病例患者结局的变化。在这项单中心队列研究中,纳入了 2006 年 1 月 1 日至 2015 年 12 月 31 日期间开始 PD 的新发病例患者。收集的数据包括基线人口统计学、临床、生化特征和结局。将在 2006-2010 年和 2011-2015 年期间开始 PD 的患者分别随访至 2011 年 12 月 31 日和 2016 年 12 月 31 日。比较了这两个新发病例队列的腹膜炎发生率、患者生存率和技术生存率。
共纳入 2021 例新发病例 PD 患者,平均年龄为 47.2±15.2 岁,女性占 40.6%。与 2006-2010 队列(n=1073)相比,2011-2015 年开始 PD 的患者(n=948)更年轻(46.2±14.8 岁比 48.1±15.5 岁,P=0.006),基线估计肾小球滤过率(eGFR)相似(5.81±2.41 vs 5.81±2.89 mL/min/1.73 m2,P=0.109),糖尿病的比例相当(24.9%比 25.7%,P=0.682)。2011-2015 队列的总体腹膜炎发生率低于 2006-2010 队列(0.158 比 0.161 次/年,P=0.001)。在 1、3 和 5 年末,2006-2010 队列和 2011-2015 队列的患者生存率分别为 94%、82%、64%和 97%、87%、74%(P<0.001)。多变量调整后,2011-2015 年开始 PD 的患者全因死亡率风险较低(风险比 [HR]0.77,95%置信区间 [CI]0.60-0.98)。在性别和年龄分层模型中,男性患者的全因死亡率风险显著降低(HR 0.58,95%CI0.41-0.83),年龄<65 岁的患者心血管(CV)死亡率风险显著降低(HR 0.63,95%CI0.40-0.99)(2011-2015 年比 2006-2010 年)。两组间的死亡校正技术生存率无显著差异(P=0.234)。
腹膜炎发生率和 PD 患者生存率持续改善。2011 年至 2015 年期间开始 PD 的患者预后较好。